Related references
Note: Only part of the references are listed.Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
Yook Chin Chia et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Unfolding Discoveries in Heart Failure
Walter J. Paulus
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2020)
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease
F. Bonnet et al.
DIABETES & METABOLISM (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction A Multiorgan Roadmap
Sanjiv J. Shah et al.
CIRCULATION (2016)
The HFpEF Obesity Phenotype The Elephant in the Room
Dalane W. Kitzman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Constantijn Franssen et al.
JACC-HEART FAILURE (2016)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Share Paper
